Target: Kyle Allen Diamantas, Acting Commissioner of Food and Drugs
Goal: Consider fast-track approval for mRNA cancer vaccine therapies that could revolutionize treatment options.
A potentially game-changing breakthrough has occurred in cancer research and treatment. The Food and Drug Administration (FDA) used the fast-track process to approve a pill that has shown great promise in extending the life and bettering the quality of life for patients with pancreatic cancer, one of the deadliest cancers. The pill targets a mutation (notoriously resistant to drugs) that accounts for a large percentage of pancreatic cancer cases and a number of other cancer types as well. The drug Rasonque first came into the public spotlight when former senator Ben Sasse credited it with extending his life following his pancreatic cancer diagnosis.
In related news, a revolutionary vaccine for skin cancer has made significant strides in clinical trials. This treatment uses mRNA technology to prevent recurrence of cancer in melanoma patients. The regimen preps a patient’s immune system to attack lingering cancer cells without harming healthy cells. Scientists hope to broaden its usage to other types of cancer and to possibly even combine therapies like Rasonque with the technology for even more powerful treatments. But, unlike the pancreatic cancer drug, FDA approval is still pending. Some researchers worry that a constant flow of misinformation and falsehoods about mRNA vaccines (that took hold during the COVID-19 pandemic) could stand in the way of these potentially life-saving treatments reaching patients.
Sign the petition below to demand the FDA give these therapies a closer, politics-free look.
PETITION LETTER:
Dear Commissioner Diamantas,
“I think we are within five years of us having combination therapies that essentially get rid of the cancer. We are maybe half a decade away from the post-cancer era.” An early healthcare investor of the groundbreaking researchers that produced the pancreatic cancer pill made this prediction. The “combination” in question involves the potential merging of therapies like the recently FDA-approved Rasonque with equally revolutionary mRNA cancer vaccine technologies.
But unlike Rasonque, personalized mRNA vaccines face substantial hurdles driven by wrongful and dangerous claims that mRNA-based treatments cause harm, or even cause cancer itself. Public trust is essential if these possible game-changers can come to fruition. When the time comes to consider the melanoma mRNA vaccine and similar treatments for FDA approval, please give these therapies the same respect and careful consideration you provided to the fast-tracked Rasonque.
Iconic singer and public figure Dolly Parton championed experimental treatments in her final days so she could help others live longer and healthier lives. Please follow her lead and help realize the dream of a cancer-free future.
Sincerely,
[Your Name Here]
Photo Credit: RDNE Stock Project
